Research Output per year
Fingerprint Dive into the research topics where Anna Zaniboni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 33 Similar Profiles
Seizures
Medicine & Life Sciences
Electroencephalography
Medicine & Life Sciences
Epilepsy
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Sleep
Medicine & Life Sciences
Myoclonus
Medicine & Life Sciences
Status Epilepticus
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1996 2019
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial
Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, , Mar 29 2019, In : BMC Cancer. 19, 1, 283.Research output: Contribution to journal › Article
Esophagogastric Junction
Paclitaxel
Stomach
Maintenance
Drug Therapy
1
Citation
(Scopus)
Gastric cancer: Translating novels concepts into clinical practice
Salati, M., Orsi, G., Smyth, E., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P. & Cascinu, S., Sep 1 2019, In : Cancer Treatment Reviews. 79, 101889.Research output: Contribution to journal › Review article
Stomach Neoplasms
Continuity of Patient Care
Survival
Combination Drug Therapy
Biomarkers
1
Citation
(Scopus)
Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy
Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, , Nov 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 33, p. 3099-3110 12 p.Research output: Contribution to journal › Article
Open Access
Disease-Free Survival
Colorectal Neoplasms
Epidermal Growth Factor Receptor
Leucovorin
Survival
3
Citations
(Scopus)
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
Rimassa, L., Bozzarelli, S., Pietrantonio, F., Cordio, S., Lonardi, S., Toppo, L., Zaniboni, A., Bordonaro, R., Di Bartolomeo, M., Tomasello, G., Dadduzio, V., Tronconi, M. C., Piombo, C., Giordano, L., Gloghini, A., Di Tommaso, L. & Santoro, A., Jun 2019, In : Clinical Colorectal Cancer. 18, 2, p. 125-132.e2Research output: Contribution to journal › Article
Colorectal Neoplasms
Epidermal Growth Factor Receptor
ARQ 197
Cetuximab
Disease-Free Survival
2
Citations
(Scopus)
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials
Cascinu, S., Poli, D., Zaniboni, A., Lonardi, S., Labianca, R., Sobrero, A., Rosati, G., Di Bartolomeo, M., Scartozzi, M., Zagonel, V., Pella, N., Banzi, M. & Torri, V., Apr 1 2019, In : European Journal of Cancer. 111, p. 1-7 7 p.Research output: Contribution to journal › Article
Colonic Neoplasms
Neoplasms
Therapeutics
Survival
Disease-Free Survival